Open AccessAssociation of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
Author(s) -
Pierre François Laterre,
Bruno François,
Christine Collienne,
Philippe Hantson,
Robin Jeannet,
Kenneth E. Remy,
Richard S. Hotchkiss
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.16485
Subject(s) - covid-19 , immunotherapy , coronavirus , immunology , lymphocyte , medicine , disease , interleukin 2 , virology , immune system , infectious disease (medical specialty) , outbreak
This case series examines whether interleukin 7 (IL-7) is associated with restored host protective immunity in patients with severe coronavirus disease 2019 (COVID-19) and immunosuppression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom